MERCK Kommanditgesellschaft auf Aktien (MRK.DE)
EUR 134.2
(-0.26%)
EUR 134.2
(-0.26%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 8.82 Billion EUR | -14.82% |
| 2022 | 8.95 Billion EUR | 9.99% |
| 2021 | 8.14 Billion EUR | 3.18% |
| 2020 | 7.88 Billion EUR | 0.6% |
| 2019 | 7.84 Billion EUR | 3.42% |
| 2018 | 7.58 Billion EUR | -0.56% |
| 2017 | 7.62 Billion EUR | 1.34% |
| 2016 | 7.52 Billion EUR | 13.99% |
| 2015 | 6.6 Billion EUR | 16.21% |
| 2014 | 5.68 Billion EUR | 5.55% |
| 2013 | 5.38 Billion EUR | -2.96% |
| 2012 | 5.54 Billion EUR | -14.71% |
| 2011 | 6.5 Billion EUR | 12.12% |
| 2010 | 5.79 Billion EUR | 14.34% |
| 2009 | 5.07 Billion EUR | 12.2% |
| 2008 | 4.52 Billion EUR | 5.09% |
| 2007 | 4.3 Billion EUR | 57.03% |
| 2006 | 2.73 Billion EUR | 4.58% |
| 2005 | 2.61 Billion EUR | 27.98% |
| 2004 | 2.04 Billion EUR | -32.91% |
| 2003 | 3.05 Billion EUR | -1.91% |
| 2002 | 3.11 Billion EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 2.07 Billion EUR | 7.18% |
| 2024 Q1 | 1.93 Billion EUR | -6.43% |
| 2023 Q1 | 2.28 Billion EUR | 3.02% |
| 2023 Q2 | 2.18 Billion EUR | -4.38% |
| 2023 FY | 7.62 Billion EUR | -14.82% |
| 2023 Q4 | 2.06 Billion EUR | 3.45% |
| 2023 Q3 | 1.99 Billion EUR | -8.43% |
| 2022 FY | 8.95 Billion EUR | 9.99% |
| 2022 Q1 | 2.03 Billion EUR | -7.76% |
| 2022 Q2 | 2.27 Billion EUR | 11.95% |
| 2022 Q4 | 2.21 Billion EUR | -8.81% |
| 2022 Q3 | 2.43 Billion EUR | 6.77% |
| 2021 Q3 | 2.06 Billion EUR | 2.99% |
| 2021 Q4 | 2.2 Billion EUR | 6.63% |
| 2021 FY | 8.14 Billion EUR | 3.18% |
| 2021 Q1 | 1.86 Billion EUR | -21.38% |
| 2021 Q2 | 2 Billion EUR | 7.85% |
| 2020 FY | 7.88 Billion EUR | 0.6% |
| 2020 Q1 | 2 Billion EUR | 0.55% |
| 2020 Q2 | 2.01 Billion EUR | 0.35% |
| 2020 Q3 | 1.5 Billion EUR | -25.29% |
| 2020 Q4 | 2.36 Billion EUR | 57.38% |
| 2019 Q4 | 1.99 Billion EUR | 1.53% |
| 2019 Q1 | 1.98 Billion EUR | 3.13% |
| 2019 Q2 | 1.9 Billion EUR | -4.04% |
| 2019 Q3 | 1.96 Billion EUR | 3.42% |
| 2019 FY | 7.84 Billion EUR | 3.42% |
| 2018 Q4 | 1.92 Billion EUR | -1.34% |
| 2018 Q2 | 1.99 Billion EUR | 7.84% |
| 2018 Q1 | 1.84 Billion EUR | -21.49% |
| 2018 FY | 7.58 Billion EUR | -0.56% |
| 2018 Q3 | 1.94 Billion EUR | -2.41% |
| 2017 Q3 | 1.52 Billion EUR | -20.91% |
| 2017 Q2 | 1.93 Billion EUR | 6.74% |
| 2017 Q1 | 1.81 Billion EUR | -20.61% |
| 2017 FY | 7.62 Billion EUR | 1.34% |
| 2017 Q4 | 2.35 Billion EUR | 54.12% |
| 2016 Q1 | 1.5 Billion EUR | -10.85% |
| 2016 Q4 | 2.28 Billion EUR | 26.88% |
| 2016 Q3 | 1.79 Billion EUR | -7.32% |
| 2016 Q2 | 1.93 Billion EUR | 28.5% |
| 2016 FY | 7.52 Billion EUR | 13.99% |
| 2015 Q2 | 1.7 Billion EUR | 7.23% |
| 2015 FY | 6.6 Billion EUR | 16.21% |
| 2015 Q4 | 1.69 Billion EUR | 4.61% |
| 2015 Q3 | 1.61 Billion EUR | -4.99% |
| 2015 Q1 | 1.58 Billion EUR | 5.68% |
| 2014 Q4 | 1.5 Billion EUR | 5.46% |
| 2014 FY | 5.68 Billion EUR | 5.55% |
| 2014 Q1 | 1.32 Billion EUR | 28.94% |
| 2014 Q2 | 1.45 Billion EUR | 9.88% |
| 2014 Q3 | 1.42 Billion EUR | -2.03% |
| 2013 Q2 | 1.45 Billion EUR | -3.21% |
| 2013 FY | 5.38 Billion EUR | -2.96% |
| 2013 Q4 | 1.02 Billion EUR | -26.79% |
| 2013 Q3 | 1.4 Billion EUR | -3.47% |
| 2013 Q1 | 1.5 Billion EUR | 636.41% |
| 2012 FY | 5.54 Billion EUR | -14.71% |
| 2012 Q1 | 1.58 Billion EUR | -2.5% |
| 2012 Q2 | 2.02 Billion EUR | 27.51% |
| 2012 Q4 | 203.8 Million EUR | -88.26% |
| 2012 Q3 | 1.73 Billion EUR | -14.14% |
| 2011 Q2 | 1.8 Billion EUR | 29.54% |
| 2011 Q3 | 1.51 Billion EUR | -15.94% |
| 2011 Q4 | 1.62 Billion EUR | 7.05% |
| 2011 FY | 6.5 Billion EUR | 12.12% |
| 2011 Q1 | 1.39 Billion EUR | -15.96% |
| 2010 Q4 | 1.65 Billion EUR | 14.03% |
| 2010 FY | 5.79 Billion EUR | 14.34% |
| 2010 Q3 | 1.45 Billion EUR | 6.47% |
| 2010 Q1 | 1.31 Billion EUR | -13.08% |
| 2010 Q2 | 1.36 Billion EUR | 3.75% |
| 2009 Q1 | 1.2 Billion EUR | 0.0% |
| 2009 Q2 | 1.2 Billion EUR | 0.32% |
| 2009 FY | 5.07 Billion EUR | 12.2% |
| 2009 Q3 | 1.21 Billion EUR | 0.54% |
| 2009 Q4 | 1.51 Billion EUR | 24.84% |
| 2008 FY | 4.52 Billion EUR | 5.09% |
| 2007 FY | 4.3 Billion EUR | 57.03% |
| 2006 FY | 2.73 Billion EUR | 4.58% |
| 2005 FY | 2.61 Billion EUR | 27.98% |
| 2004 FY | 2.04 Billion EUR | -32.91% |
| 2003 FY | 3.05 Billion EUR | -1.91% |
| 2002 FY | 3.11 Billion EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| MPH Health Care AG | 4.22 Million EUR | -208968.841% |
| Apontis Pharma AG | 23.17 Million EUR | -37991.503% |
| Dermapharm Holding SE | 142.51 Million EUR | -6093.076% |
| Evotec SE | 222.55 Million EUR | -3865.708% |
| PharmaSGP Holding SE | 50.72 Million EUR | -17300.39% |
| SynBiotic SE | 1.5 Million EUR | -585793.158% |